| Financial Year |
March 31 2023 |
| Monetary Funds |
1,656,064,881.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
97,455,893.45 |
| Advances to Suppliers |
74,678,400.96 |
| Other Receivables |
42,015,408.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
243,837,714.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
181,721,667.85 |
| Total Current Assets |
2,295,773,966.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,500,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
2,444,728,329.35 |
| Under-construction Projects |
1,563,435,794.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,540,806,409.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,116,874.99 |
| Deferred Income Tax Assets |
67,553,818.43 |
| Other Non-Current Assets |
334,189,530.56 |
| Sub-Total of Non-Current Assets |
11,009,041,547.02 |
| Total Assets |
13,304,815,513.79 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
695,431,965.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,538,992.50 |
| Taxes Payable |
80,572,471.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
176,373,333.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,523,955.58 |
| Other Current Liabilities |
10,343,658.72 |
| Sub-Total of Current Liabilities |
1,133,560,005.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
58,501,214.26 |
| Deferred Income Tax Liabilities |
175,948,497.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
246,966,295.79 |
| Total Liabilities |
1,380,526,301.70 |
| Paid-In Capital(Or Share Stock) |
929,138,953.00 |
| Capital Surplus |
7,207,102,231.71 |
| Surplus Reserve |
31,563,109.20 |
| LESS:Treasury Stock |
137,920,000.00 |
| Undistributed Profits |
2,424,764,529.16 |
| Minority Stockholder's Interest |
1,469,640,389.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,454,648,823.07 |
| Owner's Equity（Stockholder's Equity） |
11,924,289,212.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,304,815,513.79 |
